What is VitaFOXO (VITAFOXO)?
This project will design a new RNA therapeutic that nudges the longevity-linked FOXO3 gene into its health-promoting form to halt the tissue breakdown behind degenerative disc disease—opening a precise, scalable route to drugs that extend healthspan. Dr. Lorna Harries’ lab has identified an innovative way to modulate FOXO3, a well known and yet undrugged longevity target, and propose leveraging it to address chronic lower back pain stemming from degenerative disc disease.
How does VitaFOXO work?
They plan to make short, lab-made modified RNA molecules (antisense oligonucleotides) that selectively switch FOXO3’s “good” message on, first in human cells and mini-disc models. Success would yield 1) a lead drug candidate, 2) proof it can restore disc health, and 3) the data needed for patenting and further development. The same molecules could later be adapted to treat many other age-related conditions, helping people stay healthy for longer.
Where can you buy VitaFOXO?
VitaFOXO (VITAFOXO) is traded on a wide range of centralized and decentralized exchanges. The most liquid markets for VITAFOXO sit on tier-1 venues - the sort of exchanges where institutional desks and professional market makers rebalance continuously - which is what keeps the spread tight and the last price tied closely to fair value.
You can open the Markets section above to see the live list of exchanges quoting VITAFOXO, sorted by 24-hour volume. Each row links to the venue's trade page so you can go directly from research to execution without copying the ticker around by hand.
What is the daily trading volume of VitaFOXO (VITAFOXO)?
The reported 24-hour trading volume of VitaFOXO is $131.99. Volume is a live reading of how much VITAFOXO changed hands across all tracked exchanges in the past day and tends to rise during periods of price discovery and fall during consolidation.
For traders, the ratio between volume and market cap is often more informative than either number on its own: a high vol-to-mcap ratio indicates liquid, actively traded supply, while a low ratio suggests that most holders are sitting on the asset.